Study of SMT-NK Inj. Plus Pembrolizumab vs Pembrolizumab Monotherapy in Patients With Advanced Biliary Tract Cancer
Clinical trial NCT05429697 · UNKNOWN
Trial details
- NCT number
- NCT05429697
- Sponsor
- SMT bio Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-09
- Primary completion
- 2025-01-08
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.